Rosai-Dorfman Disease: From Rare to Understood

Date:
Tuesday, February 18, 2025
Time:
2:00 PM - 3:15 PM
Location:
Live KUDO Webinar
 

Webinar Overview

Dr. Gaurav Goyal, from the University of Alabama Birmingham will be exploring the ways Rosai-Dorfman Disease has gone from just a rare disease to a more understood disease.

It's FREE to attend, however registration is required.

(**Once registration is completed, you will be sent a link to the Kudo webinar once it is created.).

SPEAKER BIO

Gaurav Goyal, MD – University of Alabama at Birmingham
Dr. Goyal was born and raised in a small town in India. He obtained his medical school diploma from Smt. N.H.L. Municipal Medical College in Ahmedabad, India, in 2011. Subsequently, he moved to the United States to complete a residency in Internal Medicine from Creighton University Medical Center, Omaha, Nebraska in 2016. During his residency, he developed a special interest in hematology-oncology and went on to pursue a fellowship in the same from Mayo Clinic, Rochester, Minnesota from 2016-2019. 

During his fellowship, he developed a unique focus in a rare group of blood diseases called histiocytic disorders, including Erdheim-Chester disease, Langerhans cell histiocytosis, and Rosai-Dorfman disease. He conducted multiple studies describing the epidemiology, treatments, and outcomes of patients with histiocytosis which led to the establishment of the first of its kind multidisciplinary Histiocytosis Working Group. He has led national and international guidelines on the diagnosis and management of these rare disease entities. He was subsequently recruited to join the Hematology-Oncology division at University of Alabama at Birmingham as an Assistant Professor in 2019. 

 Dr. Goyal established the histiocytosis program after moving to UAB and expanded the Histiocytosis Working Group to include members from UAB. He continues to conduct clinical, translational, and outcomes research in histiocytosis at his current position. He has developed a special interest in survivorship research with ongoing projects evaluating the burden of morbidity and mortality among individuals with histiocytic disorders.

**** If you run into any challenges with registering for the event, please email us at outreach@histio.org for assistance. We look forward to seeing you!